Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen

Journal of Experimental Medicine

Volumn 183, Issue 3, 1996, Pages 1137-1140

  Wang, Rong Fu ^a   Parkhurst, Maria R ^a   Kawakami, Yutaka ^a   Robbins, Paul F ^a   Rosenberg, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; CELLULAR IMMUNITY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MELANOMA; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR ASSOCIATED LEUKOCYTE;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; BASE SEQUENCE; CELL LINE; CERCOPITHECUS AETHIOPS; CYTOTOXICITY, IMMUNOLOGIC; DNA PRIMERS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERLEUKIN-2; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; OPEN READING FRAMES; OXIDOREDUCTASES; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; PROTEIN BIOSYNTHESIS; PROTEINS; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029862690     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.3.1131     Document Type: Article

References (41)

1. Rosenberg, S.A., B.S. Packard, P.M. Aebersold, D. Solomon, S.L. Topalian, S.T. Toy, P. Simon, M.T. Lotze, J.C. Yang, C.A. Seipp, et al. 1988. Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. Preliminary report. N. Engl. J. Med. 319:1676-1680.
2. Rosenberg, S.A., J.Y. Yannelli, and J C. Yang. 1994. Treatment of patients with metastatic melanoma using autologous tumor-infiltrating lymphocytes and interleukin-2. J. Natl. Cancer Inst. 86:1159-1166.
3. Boon, T., J.-C. Cerottini, B. Van Den Eynde, P. Van der Bruggen, and A. Van Pel. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:337-365.
4. Houghton, A.N. 1994. Cancer antigens: immune recognition of self and altered self. J. Exp. Med. 180:1-4.
5. Tsomides, T.J., and H.N. Eisen. 1994. Commentary: T-cell antigens in cancer. Proc. Natl. Acad. Sci. USA. 91:3487-3489.
6. Pardoll, D.M. 1994. News and views: a new look for the 1990s. Nature (Lond.). 369:357-358.
7. Rosenberg, S.A. 1995. The development of new cancer therapies based on the molecular identification of cancer regression antigens. The Cancer Journal from Scientific American 1:90-100
8. Van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. DePlaen, B. Van Den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash. DC). 254:1643-1647.
9. Gaugler, B., B. Van Den Eynde, P. Van der Bruggen, P. Romero, J.J. Gaforio, E. De Plaen, B. Lethe, F. Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179:921-930.
10. Boel, P., C. Wildmann, M.L. Sensi, R. Brasseur, J.C. Renauld, P. Coulie, T. Boon, and P. Van der Bruggen. 1995. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity. 2:167-175.
11. Brichard, V., A. Van Pel, f. Wölfel, C. Wölfel, E. De Plaen, B. Lethë, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489-495.
12. Robbins, P.F., M. El-Gamil, Y. Kawakami, E. Stevens, J. Yannelli, and S.A. Rosenberg. 1994. Recognition of tyrosinase by tumor infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res. 54:3124-3126.
13. Kawakami, Y., S. Eliyahu, C.H. Delgaldo, P.F. Robbins, L. Rivoltini, S.L. Topalian, T. Miki, and S.A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA. 91:3515-3519.
14. Coulie, P.G., V. Brichard, A. Van Pel, T Wolfel, J. Schneider, C. Traversari, S. Mattei, E.D. De Plaen, C. Lurquin, J-P. Szikora, et al. 1994. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180:35-42.
15. Bakker, A.B.H., M.W.J. Schreurs, A.J. de Boer, Y. Kawakami, S.A. Rosenberg, G.J. Adema, and C.G. Figdor. 1994. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179:1005-1009.
16. Kawakami, Y., S. Eliyahu, C.H. Delgado, P.F. Robbins, K. Sakaguchi, E. Appella, J.R. Yannelli, G.J. Adema, T. Miki, and S.A. Rosenberg. 1994. Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA. 91:6458-6462.
17. Topalian, S., D. Solomon, F.P. Avis, A.E. Chang, D.L. Freeksen, W.M. Linehan, M.T. Lotze, C.N. Robertson, C.A. Seipp, P. Simon, et al. 1988. Immunotherapy of patients with advanced cancer using tumor infiltrating lymphocytes and recombinant interleukin-2: a pilot study. J. Clin. Oncol. 6:839-853.
18. Wang, R.F., P.F. Robbins, Y. Kawakami, X.-Q. Kang, and S.A. Rosenberg. 1995. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. Exp. Med. 181:799-804.
19. Mattes, M.J., T.M. Thomson, L.J. Old, and K.O. Lloyd. 1983. A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum. Int. J. Cancer. 32:717-721.
20. Vijayasyradhi, S., B.B. Bouchard, and A.N. Houghton. 1990. The melanoma antigen gp75 is the human homologue of mouse b (brown) locus gene. J. Exp. Med. 171:1375-1380.
21. Kozak, M. 1989. The scanning model for translation: an update. J. Cell Biol. 108:229-241.
22. Hann, S.R. 1994. Regulation and function of non-AUG-initiated proto-oncogenes. Biochimie. 76:880-886.
23. Muralidhar, S., S.P. Becerra, and J.A. Rose. 1994. Site-directed mutagenesis of adeno-associated virus type 2 structural protein initiation codons: effects on regulation of synthesis and biological activity. J. Virol. 68:170-176.
24. Falk, K., O. Rotzschke, M. Takiguchi, B. Grahovae, V. Gnau, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1994. Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules. Immunogenetics, 40:238-241.
25. Wolfel, T., A. Van Pel, V. Brichard, J. Schneider, B. Seliger, K.-H. Meyer Zum Buschenfelde, and T. Boon. 1994. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol. 24: 759-764.
26. Kawakami, Y., S. Eliyahu, K. Sakaguchi, P.F. Robbins, L. Rivoltini, J.B. Yannelli, E. Appella, and S.A. Rosenberg. 1994. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180:347-352.
27. Cox, A.L., J. Skipper, Y. Cehn, R A. Henderson, T.L. Darrow, J. Shabanowitz, V.H. Engelhard, D.F. Hunt, and C.L. Slingluff. 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science (Wash. DC). 264:716-719.
28. Townsend, A., C. Ohlen, M. Rogers, J. Edwards, S. Mukherjee, and J. Bastin. 1994. Source of unique tumor antigens. Nature (Lond.). 371:662.
29. Descombes, P., and U. Schibler. 1991. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell. 67:569-579.
30. Ossipow, V., P. Descombes, and U. Sch-ibler. 1993. CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with -different transcription activation potentials. Proc. Natl. Acad. Sci. USA. 90:8219-8223.
31. Shaw, M.W., P.W. Choppin, and R.A. Lamb. 1983. A previously unrecognized influenza B virus glycoprotein from a bicistronic mRNA that also encodes the viral neuraminidase. Proc. Natl. Acad. Sci. USA. 80:4879-4883.
32. Fajardo, J.E., and A. Shatkin. 1990. Translation of bicistronic viral mRNA in transfected cells: regulation at the level of elongation. Proc. Natl. Acad. Sci. USA. 87:328-332.
33. Spiropoulou, C.F., and S.T. Nichol. 1993. A small highly basic protein is encoded in overlapping frame within the P gene of vesicular stomatitis virus. J. Virol. 67:3103-3110.
34. Schwartz, S., B.K. Felber, and G.N. Pavlakis. 1992. Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs. Mol. Cell. Biol. 12:207-219.
35. Rammensee, H.G., T. Friede, and S. Stevanoviic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics. 41: 178-228.
36. Tai, T., M. Eisinger, S. Ogata, and K.O. Lloyd. 1983. Glycoproteins as differentiation markers in human malignant melanoma and melanocytes. Cancer Res. 43:2773-2779.
37. Thomson, T.N., J.M. Mattes, L. Roux, L.J. Old, and K.O. Lloyd. 1985. Pigmentation-associated glycoprotein of human melanoma and melanocytes: definition with a mouse monoclonal antibody. J. Invest. Dermatol. 85:169-174.
38. Thomson, T.N., F.X Real, S. Mutakami, C. Cordon-Cardo, L.J. Old, and A.N. Houghton. 1988. Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies. J. Invest. Dematol. 90:459-466.
39. Boon, T., and A. Van Pel. 1989. T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis. Immunogenetics. 29:75-79.
40. Fischer Kirsten, L. 1991. Do we need a pepton hypothesis? Immunogenetics. 34:1-4.
41. Quelle, D.E., F. Zindy, R.A. Ashmun, and C.J. Sherr. 1995. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 83:993-1000.